We are investing in new technologies and more lab capacity to drive our science further and faster, with an unwavering commitment to quality and patient safety.
Teligent, Inc. Ticker TLGT. Exchange NASDAQ More ... Teligent, Inc. reports have an aggregate usefulness score of 4.8 based on 69 reviews. ... 2020 Annual Report ...
Missing: relations | Show results with:relations
Rating
· Review by Smartkarma Insight Providers
Connect to Investor Relations and Research Analysts covering Teligent Inc (TLGT US, TLGT.O, TLGT)
People also ask
Is Teligent still in business?
What does Teligent do?
$12.82
Investor Relations Contact · (610) 251-1000 · InvestorRelations@triumphgroup.com.
Missing: tlgt | Show results with:tlgt
As of March 25, 2020, the registrant had 53,899,495 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE.
Teligent Inc (NASDAQ:TLGT) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in ...
Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Teligent, Inc. (TLGT) using our online tools.
Jul 21, 2017, 08:00 ET Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2% ... Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty ...
Real-time Price Updates for Teligent Inc (TLGT-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more.
As of 2024-03-11, the Fair Value of Teligent Inc (NEW JERSEY) (TLGT) is -3.90 USD. This value is based on the Peter Lynch's Fair Value formula.
Missing: relations | Show results with:relations